Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Kaplan

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
BMJ Open|March 11, 2022
Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trialsNurulamin M Noor, Sharon B Love, Talia Isaacs, et al.
Plos One|March 9, 2013
Increasing transfers-out from an antiretroviral treatment service in South Africa: patient characteristics and rates of virological non-suppressionMweete D Nglazi, Richard Kaplan, Catherine Orrell, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 19, 2013
Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART servicesMweete Debra Nglazi, Richard Kaplan, Judy Caldwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2016
<i>BRAF</i> and <i>NRAS</i> Locus-Specific Variants Have Different Outcomes on Survival to Colorectal CancerMatthew G Summers, Christopher G Smith, Timothy S Maughan, et al.
Plos One|March 5, 2013
The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South AfricaKaren Schneider, Chidi Nwizu, Richard Kaplan, et al.
European Urology|September 23, 2017
Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)Rita Faria, Marta O Soares, Eldon Spackman, et al.
European Urology|February 22, 2018
Re: Jochen Walz. The "PROMIS" of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis? Eur Urol 2018;73:31-2Rita Faria, Marta O Soares, Eldon Spackman, et al.
The Journal of Urology|February 11, 2003
Transvaginal radio frequency treatment of the endopelvic fascia: a prospective evaluation for the treatment of genuine stress urinary incontinenceRoger R Dmochowski, Mark Avon, James Ross, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2019
Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variantsMatthew G Summers, Timothy S Maughan, Richard Kaplan, et al.
European Urology Focus|February 4, 2016
The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An UpdateAhmed El-Shater Bosaily, Christopher Parker, Louise C Brown, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
BMJ Open|March 11, 2022
Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trialsNurulamin M Noor, Sharon B Love, Talia Isaacs, et al.
Plos One|March 9, 2013
Increasing transfers-out from an antiretroviral treatment service in South Africa: patient characteristics and rates of virological non-suppressionMweete D Nglazi, Richard Kaplan, Catherine Orrell, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 19, 2013
Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART servicesMweete Debra Nglazi, Richard Kaplan, Judy Caldwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2016
<i>BRAF</i> and <i>NRAS</i> Locus-Specific Variants Have Different Outcomes on Survival to Colorectal CancerMatthew G Summers, Christopher G Smith, Timothy S Maughan, et al.
Plos One|March 5, 2013
The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South AfricaKaren Schneider, Chidi Nwizu, Richard Kaplan, et al.
European Urology|September 23, 2017
Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)Rita Faria, Marta O Soares, Eldon Spackman, et al.
European Urology|February 22, 2018
Re: Jochen Walz. The "PROMIS" of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis? Eur Urol 2018;73:31-2Rita Faria, Marta O Soares, Eldon Spackman, et al.
The Journal of Urology|February 11, 2003
Transvaginal radio frequency treatment of the endopelvic fascia: a prospective evaluation for the treatment of genuine stress urinary incontinenceRoger R Dmochowski, Mark Avon, James Ross, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2019
Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variantsMatthew G Summers, Timothy S Maughan, Richard Kaplan, et al.
European Urology Focus|February 4, 2016
The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An UpdateAhmed El-Shater Bosaily, Christopher Parker, Louise C Brown, et al.
Pageof 15